Rocket Lab Stock Down 59% in Six Months Despite Strong Neutron Rocket Bookings and $3.57B Backlog

Neutral (0.1)Impact: Medium

Published on · By VibeTrader

Get AI analysis of the markets behind this story

Build and test trading strategies with AI. 3-day free trial · Cancel anytime

Try VibeTrader free

Rocket Lab (RKLB) has experienced significant stock price deterioration, losing 59.4% over the past six months compared to a 3.1% decline for the S&P 500, with shares closing 66.1% below their May 27 high of $150.23 as of November 19, 2026 [1]. Despite this weakness, the company has achieved notable commercial success with its next-generation Neutron rocket program, which has secured its first 16 launches with customers paying deposits before the vehicle has even launched [1]. In fiscal Q3 2026 alone, Rocket Lab signed eight new Neutron launches worth approximately $515 million—exceeding the entire $199 million in revenue generated by the Launch Services business during fiscal 2025 [1].

The Neutron program demonstrates strong pricing power, with several of the eight new launches sold at a raised base price of $70 million each, which management designated as the new baseline with expectations for further price increases [1]. Management indicated the company could have booked additional Neutron launches during the quarter but strategically held out for higher prices, suggesting confidence in demand [1]. Rocket Lab ended fiscal Q3 2026 with a substantial backlog of $3.57 billion against $882 million in trailing 12-month revenue, with launches representing approximately 52% of that backlog [1]. Management expects 32.9% of the backlog to convert to revenue within 12 months, with the remainder due further out [1].

However, the company faces near-term challenges that may explain the stock's weakness. Rocket Lab now expects Neutron's first launch in 2027 after discovering voids in the forward dome of the rocket's propellant tank, with management preferring frequent updates over specific timelines to avoid missing dates [1]. The company posted an operating loss of $244 million over the past 12 months and expects Neutron spending to remain elevated until the first launch [1]. Additionally, the stock's valuation appears stretched at 37.7 times sales compared to 3.1 times for the S&P 500, suggesting much of the growth is already priced in [1]. Over the past 12 months, RKLB returned 19.2% against 9.7% for the index, indicating recent underperformance despite the strong booking momentum [1].

CONCLUSION

Rocket Lab faces a valuation disconnect between its strong Neutron bookings and backlog ($3.57 billion) and its current stock performance, trading at a significant premium multiple (37.7x sales) while the company remains unprofitable. The key catalyst for stock recovery will be successful Neutron launches in 2027 and the company's path to profitability within six months of the first successful test flight, though near-term execution risks and high spending levels continue to pressure the stock.

Turn today's news into tomorrow's trade.

Build trading strategies without code, test them against historical data, and connect your broker account.

Try VibeTrader free

3-day free trial · Cancel anytime

Feel free to email us at team@vibetrader.com

Was this page helpful?

Related Articles

European stocks suffer worst week in months as DAX plunges 7.29%, triggering flight to safety in government bonds

European equity markets experienced a severe selloff during the week ending Nove...

Read full article

EconomyBookings Expands Beyond Car Rentals with Launch of Flight Booking Service Covering 300+ Airlines

EconomyBookings, an online car rental aggregator based in Riga, Latvia, announce...

Read full article

New Balance Extends Shohei Ohtani Contract Through Playing Career, Names Research Lab After Superstar

New Balance and Shohei Ohtani have agreed to extend their partnership contract t...

Read full article
Sources: trefis.com